GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Gensight Biologics SIGHT.PA · EUR

Health Care · Euronext Paris · 🇫🇷 France

Compare

0.08

+11.85%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Gensight Biologics — daily SIGHT

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Gensight Biologics on TradingView ↗
Market value
€7.4m
Last close × shares
Volume
1.1m
Shares, 9 Nov 2026

About Gensight Biologics

Its shares trade on Euronext Paris under the ticker SIGHT.PA. It has been listed since 13 July 2016. In the fiscal year to 31 December 2025, it reported revenue of €1,000 and a net loss of €12.0m. At that date it held total assets of €8.3m and shareholders' equity of −€24.9m.

GenSight Biologics SA is a clinical-stage gene therapy company. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2016-07-13. The firm develops and commercializes gene therapy-based treatments of retinal degenerative diseases. The company develops approaches to prevent retinal degeneration in selected pathological conditions and to restore vision in patients suffering from low vision or blindness. The firm intends notably to develop a gene replacement therapy for Leber's hereditary optic neuropathy (LHON) and an optogenetic therapy for retinitis pigmentosa (RP).

Figures and description from our data supplier, not checked against the company's own report.

More about Gensight Biologics →

Latest on Gensight Biologics

Our reporting

We have not reported on Gensight Biologics yet.

Next results

19 Mar 2027

Due on 19 Mar 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Gensight Biologics's ticker?

Gensight Biologics trades as SIGHT.PA on Euronext Paris, under ISIN FR0013183985.

What was Gensight Biologics's last closing price?

0.08 on 9 Nov 2026. The figure is in EUR and is never converted.

When does Gensight Biologics next report results?

Results are expected on 19 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.